Genetic Engineering & Biotechnology News
April 1, 2009
Enforceable Diagnostic Method Patents: Though ITC Provides Some Protection Abroad, States Can Trample Rights Here at Home
Related Content
- PodcastNovember 16, 2026
Inside the AI Deals Rewiring Drug Discovery
- AlertNovember 11, 2026
Trade Secret and Copyright Claims Are Not Mutually Exclusive in Software Disputes
- AlertNovember 10, 2026
Delaware Court of Chancery Holds That “Transaction-Specific Control” Has No Place in Delaware’s Safe Harbor Statute
- Big Molecule WatchNovember 9, 2026
Teva and Samsung Bioepis Enter Into Licensing Agreement to Commercialize Etanercept and Infliximab Biosimilars in the U.S.
- Big Molecule WatchNovember 9, 2026
Fresenius and WuXi Biologics Enter Development Agreement
- Big Molecule WatchNovember 6, 2026
Theriva Biologics Sells Antibiotic-Degrading Enzyme Portfolio to Biossil Labs
- Big Molecule WatchNovember 6, 2026
Adalvo Expands Biosimilars Portfolio Through Acquisition of Romiplostim Biosimilar Program from Enzene
- Big Molecule WatchNovember 6, 2026
FDA Approves Xbrane’s LUCAMZI™, a Biosimilar to LUCENTIS®
- Press ReleaseNovember 18, 2026
Goodwin Advises Omniose on Acquisition by AstraZeneca
- Market Recognition17 November 2026
Goodwin Wins Deal Adviser of the Year at the 2026 European Lifestars Awards
- Press ReleaseNovember 16, 2026
Goodwin Advises Pharmakon on Intellectual Property Aspects of $150 Million Loan for CorMedix
- Press ReleaseNovember 16, 2026
Goodwin Advises Royalty Pharma on Transactional and Intellectual Property Aspects of Royalty Stream Purchase From AstraZeneca
- Press ReleaseNovember 16, 2026
Goodwin Advises Calytrix Bio on Its Agreement To Be Acquired by Eli Lilly for up to $1.5 Billion
- Market RecognitionNovember 13, 2026
Goodwin Wins Healthcare and Pharmaceutical Corporate Practice of the Year
- Press ReleaseNovember 13, 2026
Goodwin Advises Ascidian Therapeutics on Entering Strategic Agreement With Exegenesis Bio
- Press ReleaseNovember 13, 2026
Goodwin Advises PepGen on $125 Million Public Offering of Common Stock